• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Agfa signs definitive agreements for Mitra purchase

Article

Agfa-Gevaert has executed the definitive agreements for acquisition of long-time technology partner Mitra. The deal, which is expected to close in early January, is subject only to completion of the premerger clearance process. The two companies

Agfa-Gevaert has executed the definitive agreements for acquisition of long-time technology partner Mitra. The deal, which is expected to close in early January, is subject only to completion of the premerger clearance process. The two companies announced the signing of a letter of intent regarding the sale in late September. Mitra, a provider of imaging and information management systems for the healthcare enterprise, has played an integral role in the development and success of Agfa's IMPAX PACS solutions for the past 10 years. Mitra will be managed as a separate business unit‹the company structure, management team, and all employees will be retained.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.